Title	Publication Date	Language	Citations
A psychometric comparison of the Calgary depression scale for schizophrenia and the Hamilton depression rating scale	1996/05/01	English	163
C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia	2007/07/01	English	163
Schizophrenia patients demonstrate a distinctive pattern of decision-making impairment on the Iowa Gambling Task	2005/01/01	English	162
The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophrenia	2015/09/01	English	162
Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia	2013/08/01	English	162
Neurocognitive impairment across the lifespan in schizophrenia: an update	2005/04/01	English	162
Histories of childhood maltreatment in schizophrenia: Relationships with premorbid functioning, symptomatology, and cognitive deficits	2005/07/01	English	162
Determining the chronology and components of psychosis onset: The Nottingham Onset Schedule (NOS)	2005/12/01	English	162
Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): Results of a 6-week, randomized, placebo-controlled study	2007/07/01	English	161
Generalized deficit in all core components of empathy in schizophrenia	2009/03/01	English	160
Validation of a physical activity assessment tool for individuals with schizophrenia	2006/02/01	English	158
Regional thinning of the cerebral cortex in schizophrenia: Effects of diagnosis, age and antipsychotic medication	2008/01/01	English	158
Infectious agents associated with schizophrenia: A meta-analysis	2012/04/01	English	158
Interaction among subsystems within default mode network diminished in schizophrenia patients: A dynamic connectivity approach	2016/01/01	English	158
Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia	2005/12/01	English	157
Cannabis with high cannabidiol content is associated with fewer psychotic experiences	2011/08/01	English	157
Subjective and objective quality of life in schizophrenia	2008/01/01	English	157
Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8	2010/08/01	English	157
Antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia	2018/07/01	English	156
Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: A gene ontology study	2005/11/15	English	156
Catatonia in DSM-5	2013/10/01	English	156
Neural correlates of reward processing in schizophrenia — Relationship to apathy and depression	2010/05/01	English	154
Impaired recognition and expression of emotional prosody in schizophrenia: Review and meta-analysis	2007/11/01	English	153
A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis	2011/01/01	English	152
Diminished plasma oxytocin in schizophrenic patients with neuroendocrine dysfunction and emotional deficits	2008/01/01	English	151
Gastrointestinal inflammation and associated immune activation in schizophrenia	2012/06/01	English	151
Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study	2008/10/01	English	149
Schizophrenia and the inferior parietal lobule	2007/12/01	English	149
On the HORYZON: Moderated online social therapy for long-term recovery in first episode psychosis	2013/01/01	English	148
A genome-wide meta-analysis identifies novel loci associated with schizophrenia and bipolar disorder	2010/12/01	English	148